WE CAN SAVE LIVES TOGETHER
Since 1998, the Harry Perkins Institute of Medical Research has made significant discoveries into the diseases that most affect our families, in particular heart disease, diabetes and cancer. Over 200 researchers, scientists and clinicians are housed in two state-of-the-art research facilities. The Perkins is committed to giving yourself and those you love the opportunity to live longer, healthier and better lives by helping WA’s best medical researchers beat the world’s toughest diseases.
Research teams dedicated to finding answers to defeat cancers are funded from the MACA Cancer 200 each year.
In 2024, this is how you are having an impact.
supporting world class cancer research
Your generous funding is driving vital cancer research in melanoma and liver cancer. Professor Jonas Nilsson's team focuses on Car-T cell-therapy for melanoma, an innovative treatment where immune cells are enhanced outside the body and reintroduced to combat the disease. An upcoming clinical trial holds potential to revolutionise the treatment of melanoma and other potentially other cancers.
Professor Jonas Nilsson
Liver cancer, which has a grim five-year survival rate of 18% poses as a serious future global health risk. With the support of Ride funds, Perkins researchers, are working to change that statistic through RNA-technology. They've identified a micro-RNA, specifically microRNA-7, as a possible effective inhibitor of liver cancer. Remarkably making drug-resistant liver cancer cells receptive to the same drug again.
Your support fuels this global, interdisciplinary effort, offering hope in the battle against these deadly diseases.
Emeritus Professor George Yeoh,
Professor Peter Leedman AO
Professor Ryan Lister
INVESTING IN COLLABORATION
You are helping Professor Ryan Lister lead a game-changing cancer research project with a real global impact. Using advanced genomics, his team explores T-cell immunity in viral infections.
These committed researchers map the genes and molecules involved in a successful immune response, aiming to enhance immunotherapy for solid cancers. Understanding immune system memory and activation could lead to strengthening and creating more potent T-cells for cancer treatment. This research may lead to more targeted approaches to treatments and better health outcomes for our loved ones.
BACKING TOMORROW'S DISCOVERIES
Perkins' Safe Harbour program protects early to mid-career researchers by providing fully funded three-year fellowships. Instead of struggling for grants, these bright minds focus on advancing vital research.
Your funds will back a Cancer 200 Safe Harbour Fellow, potentially paving the way for the next world-class cancer discovery. Because of your support of these passionate researchers’ emerging talents, we may be one step closer to a big breakthrough in cancer research.